Minn. Appellate Court Will Reconsider Access To GlaxoSmithKline Documents On Re-Importation
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline may be ordered to make public 45 documents related to Minnesota Attorney General's claim that the company attempted to boycott Canadian pharmacies.
You may also be interested in...
Manufacturers Should Perform Due Diligence On Potential Distributors, Attorney Advises
Drug companies should audit wholesalers' facilities to reduce counterfeits, Arnall Golden Gregory attorney Alan Minsk tells Healthcare Distribution Management Association.
Purdue Signs On To Market Labopharm's Once-Daily Tramadol
Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.
Merck KGaA Boosts U.S. Generic Market Presence With Genpharm Expansion
Genpharm opens office in New York headed by former Able CEO Robert Mauro.